Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Sector Analysis

UpdatedAug 01, 2025
DataAggregated Company Financials
Companies1393
  • 7D-4.2%
  • 3M-4.9%
  • 1Y-14.3%
  • YTD-7.2%

Over the last 7 days, the Healthcare industry has dropped 1.8%, driven by a pullback from Eli Lilly of 8.1%. In contrast, Alnylam Pharmaceuticals has gained 20%. However, the industry is down 11% over the past year. Earnings are forecast to grow by 15% annually.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 01 Aug 2025US$5.5tUS$3.1tUS$127.6b23.4x43.1x1.8x
Sun, 29 Jun 2025US$5.5tUS$3.0tUS$127.5b24.8x43.1x1.8x
Tue, 27 May 2025US$5.3tUS$3.0tUS$126.9b22.6x41.7x1.7x
Thu, 24 Apr 2025US$5.3tUS$2.7tUS$98.1b24.8x54x2x
Sat, 22 Mar 2025US$5.7tUS$2.6tUS$81.8b26.6x70x2.2x
Mon, 17 Feb 2025US$5.8tUS$2.6tUS$82.1b26.7x70.8x2.2x
Wed, 15 Jan 2025US$5.8tUS$2.9tUS$78.9b28.1x73.9x2x
Fri, 13 Dec 2024US$6.0tUS$2.9tUS$77.6b28.6x77x2x
Sun, 10 Nov 2024US$6.3tUS$2.9tUS$76.0b28.3x82.8x2.2x
Tue, 08 Oct 2024US$6.2tUS$2.8tUS$60.1b30.3x102.4x2.2x
Thu, 05 Sep 2024US$6.3tUS$2.8tUS$60.4b31.6x104.2x2.2x
Sat, 03 Aug 2024US$6.4tUS$2.9tUS$63.3b31.8x100.9x2.2x
Mon, 01 Jul 2024US$6.2tUS$2.8tUS$62.2b30.5x99.3x2.2x
Wed, 29 May 2024US$6.1tUS$2.8tUS$63.8b30.3x96.3x2.2x
Fri, 26 Apr 2024US$6.0tUS$2.8tUS$72.2b30.4x82.7x2.1x
Sun, 24 Mar 2024US$6.2tUS$2.8tUS$82.2b31.8x75.9x2.2x
Tue, 20 Feb 2024US$6.3tUS$2.8tUS$82.6b30.1x75.9x2.2x
Thu, 18 Jan 2024US$6.3tUS$2.8tUS$90.8b32x69.5x2.2x
Sat, 16 Dec 2023US$6.1tUS$2.8tUS$91.5b32.3x66.5x2.2x
Mon, 13 Nov 2023US$5.7tUS$2.8tUS$91.1b26.3x62.2x2x
Wed, 11 Oct 2023US$5.9tUS$2.8tUS$98.3b26.9x60.2x2.1x
Fri, 08 Sep 2023US$6.1tUS$2.8tUS$98.6b26.9x62x2.2x
Sun, 06 Aug 2023US$6.1tUS$2.8tUS$100.3b28.8x60.8x2.2x
Tue, 04 Jul 2023US$6.0tUS$2.7tUS$110.3b26.4x54.4x2.2x
Thu, 01 Jun 2023US$5.8tUS$2.7tUS$110.5b24.6x52.6x2.1x
Sat, 29 Apr 2023US$6.0tUS$2.5tUS$118.5b24.7x50.4x2.4x
Mon, 27 Mar 2023US$5.7tUS$2.5tUS$124.2b23.6x45.7x2.3x
Wed, 22 Feb 2023US$5.8tUS$2.5tUS$131.0b24.4x44.4x2.4x
Fri, 20 Jan 2023US$6.0tUS$2.5tUS$135.9b23x43.9x2.4x
Sun, 18 Dec 2022US$6.0tUS$2.4tUS$133.8b23.3x44.7x2.5x
Tue, 15 Nov 2022US$5.9tUS$2.4tUS$136.1b23.3x43.4x2.4x
Thu, 13 Oct 2022US$5.5tUS$2.4tUS$155.6b21x35.3x2.3x
Sat, 10 Sep 2022US$5.9tUS$2.4tUS$156.6b22.8x37.9x2.5x
Mon, 08 Aug 2022US$6.0tUS$2.4tUS$161.1b24.6x37.5x2.5x
Price to Earnings Ratio

37.5x


Total Market Cap: US$6.0tTotal Earnings: US$161.1bTotal Revenue: US$2.4tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 64.5x202320242025
Current Industry PE
  • Investors are pessimistic on the American Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 43.5x which is lower than its 3-year average PE of 64.5x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 7.7% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.4% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market-0.62%
Healthcare-4.24%
Medical Equipment-2.27%
Biotech-3.27%
Healthtech-3.40%
Healthcare Services-3.43%
Life Sciences-4.44%
Pharma-6.55%
Industry PE
  • Investors are most optimistic about the Life Sciences industry, which is trading close to its 3-year average PE ratio of 62.1x.
    • Analysts are expecting annual earnings growth of 17.0%, which is higher than its past year's earnings decline of 7.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 23% over the next 5 years.
  • However this is lower than its past earnings growth rate of 40% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALNY Alnylam PharmaceuticalsUS$392.2419.6%
+US$8.4b		46.0%PS21.8x
CVS CVS HealthUS$62.105.7%
+US$4.2b		3.4%PE14.9x
HCA HCA HealthcareUS$353.993.7%
+US$3.0b		-2.5%PE14.3x
HUM HumanaUS$249.879.0%
+US$2.4b		-30.4%PE19.1x
EW Edwards LifesciencesUS$79.314.6%
+US$2.1b		28.2%PE33x

Latest News

ALNY
US$392.24
Alnylam Pharmaceuticals
7D
19.6%
1Y
46.0%
AMGN
US$295.10
Amgen
7D
-4.4%
1Y
-12.0%
HUM
US$249.87
Humana
7D
9.0%
1Y
-30.4%
LLY
US$740.07
Eli Lilly
7D
-8.1%
1Y
-11.1%
CVS
US$62.10
CVS Health
7D
5.7%
1Y
3.4%
UNH
US$249.56
UnitedHealth Group
7D
-10.4%
1Y
-56.4%
CELC
US$39.17
Celcuity
7D
178.8%
1Y
118.3%
JNJ
US$164.74
Johnson & Johnson
7D
-2.8%
1Y
2.5%
MRK
US$78.12
Merck
7D
-7.1%
1Y
-31.4%
INCY
US$74.89
Incyte
7D
6.2%
1Y
16.3%
HIMS
US$66.18
Hims & Hers Health
7D
15.5%
1Y
257.5%
HCA
US$353.99
HCA Healthcare
7D
3.7%
1Y
-2.5%
EW
US$79.31
Edwards Lifesciences
7D
4.6%
1Y
28.2%
CI
US$267.38
Cigna Group
7D
-9.0%
1Y
-19.6%
BMY
US$43.31
Bristol-Myers Squibb
7D
-11.5%
1Y
-10.1%
PFE
US$23.29
Pfizer
7D
-8.1%
1Y
-24.0%